Afshar-Oromieh, A., Kratochwil, C., Giesel, F. L., Mier, W., & Haberkorn, U. (2015). The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: Biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions. Journal of nuclear medicine, 56(11), . https://doi.org/10.2967/jnumed.115.161299
Chicago-Zitierstil (17. Ausg.)Afshar-Oromieh, Ali, Clemens Kratochwil, Frederik L. Giesel, Walter Mier, und Uwe Haberkorn. "The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions." Journal of Nuclear Medicine 56, no. 11 (2015). https://doi.org/10.2967/jnumed.115.161299.
MLA-Zitierstil (9. Ausg.)Afshar-Oromieh, Ali, et al. "The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions." Journal of Nuclear Medicine, vol. 56, no. 11, 2015, https://doi.org/10.2967/jnumed.115.161299.